R&D Milestone definition

R&D Milestone means the applicable milestone set forth in Section 7.2(a).
Sample 1Sample 2Sample 3

Examples of R&D Milestone in a sentence

  • The Parties agree that the concept of "Contract Pennies" (CP), an economic equivalent of the combined, weighted effect of the parameters of ***, will be used to determine when an R&D Milestone is attained.

  • Following termination of this Agreement, the basis for determining whether or not a particular R&D Milestone payment is due and the amount of such payment shall be the results of testing of Designated Organisms designated by GENENCOR as in Paragraph 10.5 above.

  • Both bills would continue to clarify the definition of “payment of cash in advance” for U.S. agricultural exports to Cuba during FY2012, while S.

  • Upon agreement by the Parties based on the Steering Committee's review of the scientific data and results of the R&D Program that a particular R&D Milestone (Generation I, II, or III) was achieved, DuPont will make certain non-refundable, lump sum payments to GENENCOR.

  • Upon determination by the Steering Committee, based on its review of the scientific data and results of the Program, that a particular milestone was achieved, GCOR will make certain non-refundable, lump sum payments to EPMN ("R&D Milestone Payments").

  • In consideration for the rights granted to CureVac under this Agreement, CureVac shall pay to myNEO the one-time, non-refundable, non-creditable research milestone payments set forth in this Section 8.4 (each a "R&D Milestone Payment").

  • If it proposes to offer islanding as a service, it must successfully demonstrate islanding capability.

  • The amount reported under the column entitled "Threshold" shows the amount that would be earned if no credit was awarded under the R&D Milestone and the remaining three Milestones were achieved at threshold / minimum levels.(2) In light of the four-year equity grant of stock options in March 2019 covering the 2019-2022 period, no equity-based awards were granted to the Named Executive Officers in 2021.

  • As a result, there is a lack of substantial proof to clearly identify malicious activity within the smart grid communications, as opposed to routine activity.

  • With respect to Indications other than Melanoma and NSCLC, on a [*****] Target List-by-[*****] Target List basis, CureVac shall pay to myNEO the following one-time, non-refundable, non-creditable R&D Milestone Payments upon the first occurrence of the applicable milestone event with respect to a Product for the first [*****] Indications other than Melanoma and NSCLC.

Related to R&D Milestone

  • Milestone means an event or task described in the Implementation Plan which, if applicable, must be completed by the relevant Milestone Date;

  • Milestone 2 means achievement of annual Net Sales of at least $35,000,000 during any Calendar Year ending on or before December 31, 2024.

  • Milestone 1 means achievement of annual Net Sales of at least $20,000,000 during the Calendar Year ending on December 31, 2021.

  • Development Milestone Event has the meaning set forth in Section 7.1.

  • Development Milestone Payment shall have the meaning set forth in Section 9.2(a).

  • Project Milestone means the project milestone set forth in Schedule-J;

  • Milestone Date means the date set against the relevant Milestone in the Implementation Plan;

  • Milestone Event has the meaning set forth in Section 8.4.

  • Performance Milestone means an act or event specified in section 5.1 and described in section 9 of the EPLA.

  • Milestone Events has the meaning set forth in Section 3.3 (Milestone Payments).

  • Milestone Dates means the dates for completion of specified Project activities as contained in the Project Schedule.

  • Project Milestones means the project milestones set forth in Schedule-G;

  • Sales Milestone Payment is defined in Section 5.3.

  • Milestones means control points in the project that help to chart progress. Milestones may correspond to the completion of a key deliverable, allowing the next phase of the work to begin. They may also be needed at intermediary points so that, if problems have arisen, corrective measures can be taken. A milestone may be a critical decision point in the project where, for example, the consortium must decide which of several technologies to adopt for further development.

  • Milestone Payment means a payment identified in the Implementation Plan to be made following the issue of a Satisfaction Certificate in respect of Achievement of the relevant Milestone;

  • Milestone Payment Date has the meaning set forth in Section 2.4(a).

  • Milestone Schedule means Seller’s milestone schedule, the form of which is attached to this Agreement as Exhibit Q.

  • Milestone Failure means a failure by the Grant Recipient fully to achieve any Milestone by the relevant Milestone Date;

  • Milestone Payments has the meaning set forth in Section 4.2.

  • EBITDA Target means the Company's projected earnings before interest, taxes, one-time transition expenses, non-cash compensation expense charges, depreciation and amortization, as contained in the Company's budget for the Applicable Period and which is approved by the Board (without reference to any adjustments or revision, upwards or downwards, to such projected earnings which are subsequently approved by the Board as part of any subsequent revision to such budget), and (ii) the term "Financial Results" shall mean the Company's EBITDA calculated by reference to the Company's financial statements for the Applicable Period as filed with the Securities and Exchange Commission (the "SEC").

  • Successful Completion means that in the reasonable opinion of the Customer, Deliverables completed by the Supplier are fit for purpose, completed on time and otherwise meet all the criteria defined under this Contract;

  • Stage 2 means the construction of the second hotel and other developments facilities and amenities referred to in the Development Proposals;

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Final Completion Date means the date on which Final Completion occurs.

  • KPI Target means the acceptable performance level for a KPI as set out in each KPI;